Department of Neurosurgery


Many neurological diseases affect neuronal survival and induce neurodegeneration. The goal of our research is to identify neuroprotective and neurodegenerative cellular signaling in neurons and glial cells. Currently, we are focusing on acute and chronic neuroprotective treatments for ischemic stroke, spinal cord injury and traumatic brain injury. 



We hold weekly lab meetings to discuss the projects going on in the lab. We are scheduled to meet on  Wednesday of each month at 2:00 pm in the Neurosurgery Conference Room 102F. However, please check this website frequently for any changes to date/time.


During the Neurosurgery Residency, the NS5 year is designated as the primary research year.  The overall goal is for the resident to become familiar with techniques in molecular biology, genetics, cell culture and animal models. By working closely with Ph.D. scientists, the resident gains a greater insight into the rigorous, technical and statistical aspects of scientific research. Each resident will have the opportunity to  attend national meetings such as the RUNN course and attend a specialty meetings in their area of research, such as the annual Stroke Meeting or Annual Meeting of the Society for Neuroscience.

You can read more about the Research Education Program Plan here.



The Office of the Medical Dean provides funds to support UT Health Science Center medical students engaged in research projects with UTHSCSA faculty during the summer break. Summer stipends will be awarded for 5-8 weeks of full-time research. 

Applications are currently available online and will be due by January 15th, 2012.  The application requires input by both the medical student and his/her faculty mentor. The online application can be found here.

Each summer the Department of Neurosurgery welcomes medical students who have a keen interest in Neuroscience and Neurosurgery. The summer program is designed to instill scientific thinking, critical evaluation and reasoning skills in students and provide valuable research experience in laboratory techniques, experimental design, data collection and evaluation. At the end of the program, students are expected to present their original data at a campus-wide poster session. 

Note: Deadline has passed for Summer of 2012


Featured Story

Clinical Trial Shows Promising Success

Neurosurgery Admin

 |  Tuesday Mar 24, 2015 | Share This Item

Andrew Brenner M.D., Ph.D., and John R. Floyd II M.D., have been working together at the Cancer Therapy & Research Center to develop a new method of treating glioblastoma, an especially aggressive brain cancer. Their innovative therapy delivers radioactive liposomes directly into brain tumors using a newly designed catheter that is capable of improved surgical targeting.

Dr. Brenner is optimistic about their first patient’s encouraging results.


Researcher Spotlight
Lindsey Williams
Friday Dec 18, 2009
Sam Overley
Thursday Oct 15, 2009